Lutropin Alfa in Women at Risk of Poor Response

NCT01112358 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Stimulation

Interventions

DRUG: r-FSH
DRUG: r-hLH
DRUG: Analogous GnRH antagonist
DRUG: r-hCG
DRUG: Progesterone

Sponsor

Merck KGaA, Darmstadt, Germany